Semaglutide Risk and Rewards

Semaglutide (Ozempic©, Wegovy©) has become the leading drug of choice for many health conditions. More and more patients are using this important and versatile hormone therapy. If you feel unprepared to assist your patients on semaglutide therapy and you want to know what the latest research says on lean muscle mass (LMM) loss with this therapy or other emerging topics related to semaglutide treatment, then this is the course for you.

Semaglutide Risk and Rewards: In this 2-part program we will:

discuss the outcomes of several key clinical trials using semaglutide and other incretin agents.
focus on key practice areas of concern for both patients and healthcare professionals.
review the effects of weight loss and improved metabolic markers on lean muscle mass (LMM).
pay special attention to discussing if the loss of lean muscle mass (LMM) is maladaptive, adaptive or enhancing to an individuals health.
review the role of incretin therapy in perioperative preparation, diabetes, obesity and post-bariatric surgery.
outline what reasearch tells us about expected weight loss with various interventions.
pay specific attention to managing patients expectations when using semaglutide therapy.
review provided patient and health care provider education tools on using semaglutide therapy.

FAQ

What is this program based upon? Is it funded by a drug company?

This program is not funded by any drug or external company. This webinar was created by Michelle Archer, RD, CDE of Diabetes Training 101 Inc in response to the numerous discussions and inquiries by health professionals to learn more about this quickly evolving hormone treatment used in both obesity and diabetes management. This program is based on the semaglutide research available up to late 2024 and early 2025.

Can I use the tools from this webinar in my practice?

Yes! You can use these handouts to inform your colleagues and in your interactions with your patients. We do ask that you do not alter the handouts in any way.

How long do I have access to the program?

You will have lifetime access to the semaglutide series. It is important to note that research evidence changes and treatments evolve so the program content found in this series may become outdated or practice methods may change thereby making the content of this webinar irrelevant to metabolic management.

Learn about Diabetes Training 101 Inc.

About Diabetes Training 101.

Who We are

Learning Opportunities for Canadian Health Care Professionals

Diabetes Training Opportunities

Diabetes Presentations & Workshops

Resources for people living with diabetes

Healthy Portions Are In Your Hands

Plate Method for Healthy Eating with Diabetes

The Diabetes Myths, Misconceptions and Big Fat Lies!

View All Resources for People Living with Diabetes

Semaglutide Risk and Rewards